4.5 Article

Local and Sustained Delivery of Rifampicin from a Bioactive Ceramic Carrier Treats Bone Infection in Rat Tibia

Journal

ACS INFECTIOUS DISEASES
Volume 6, Issue 11, Pages 2938-2949

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acsinfecdis.0c00369

Keywords

Bone infection; debridement; drug release; nanohydroxyapatite; osteomyelitis; rifampicin

Funding

  1. Department of Science and Technology (DST), Ministry of Science and Technology, Government of India [DST/INT/SWD/P-11/2016]
  2. Department of Biotechnology (DBT), Ministry of Science and Technology [BT/IN/Sweden/08/AK/2017-18]
  3. Department of Science and Technology (DST) [DST/NM/NT-2018/48]
  4. Ministry of Human Resource Development (MHRD)
  5. Indian Council of Medical Research (ICMR) funded Uchhatar Avishkar Yojana (UAY) scheme [MHRD_IITK_006]
  6. IITK (MHRD, Govt. of India)
  7. CSIR, Govt. of India
  8. JC Bose Fellowship (SERB, Govt. of India)

Ask authors/readers for more resources

Next-generation treatment strategies to treat osteomyelitis with complete eradication of pathogen at the bone nidus and prevention of emergence of drug resistance is a real challenge in orthopedics. Conventional treatment strategies including long-term adherence of patients to systemic antibiotic delivery, local delivery using nondegradable vehicles, and surgical debridement are not completely effective in achieving successful results. In this study, a broad-spectrum antibiotic, rifampicin (RFP), was incorporated into a biphasic nanohydroxyapatite (nHAP)/calcium sulfate ceramic carrier (NC) system. In vivo release and distribution of rifampicin was evaluated for a period of one month by implanting NC and NC + RFP in a subcutaneous pouch in a rat model. We detected the RFP in bone and implanted NC scaffolds even after day 28 and the concentration was still higher than the minimal inhibitory concentration of RFP when it was implanted with NC in an abdominal subcutaneous pouch. Moreover, we also observed the accumulation of RFP in bone and NC when administered orally, showing strong binding between RFP and nHAP. Additionally, we generated an osteomyelitis bone infection model in the rat tibia using Staphylococcus aureus as an infective agent to evaluate the antibacterial and osteogenic efficiency of RFP containing NC as a delivery system. S. aureus mediated implant infection is a major problem in orthopedics. The results suggested that NC loaded with RFP could eradicate the pathogen completely in the bone nidus. Further, defect healing and bone formation were also evaluated by micro-CT and histological analysis demonstrating proper trabecular-type bone formation at the debridement site and complete healing of the defect when NC + RFP was implanted. Our findings provide an insight into the use of an nHAP based ceramic matrix as a carrier of rifampicin to eradicate the bone infection and simultaneously promote bone healing at the bone nidus.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available